Evidence map›Paper›PMID 28926001›Full record

ArticleTranslational psychiatry2017

Ketamine: differential neurophysiological dynamics in functional networks in the rat brain.

A Ahnaou, H Huysmans, R Biermans, N V Manyakov, W H I M Drinkenburg

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05718024 (Impact of Night-time Dexmedetomidine-esketamine Infusion on Sleep Quality of Patients With Mechanical Ventilation or High-flow Nasal Cannula Oxygen Therapy in ICU), which is not on this map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05718024 phase4completednot on this mapstarted 2023, after this paper: background citation

Impact of Night-time Dexmedetomidine-esketamine Infusion on Sleep Quality of Patients With Mechanical Ventilation or High-flow Nasal Cannula Oxygen Therapy in ICU: a Randomized Controlled Trial

TypeinterventionalSponsorPeking University First HospitalRan2023 to 2025Enrolled174ConditionsIntensive Care Unit, Mechanical Ventilation, Dexmedetomidine, EsketamineArmsDexmedetomidine-esketamine, Routine sedation and analgesia
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. A widespread internal brain state for fentanyl withdrawal.bioRxiv : the preprint server for biology · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. GM-1020: a novel, orally bioavailable NMDA receptor antagonist with rapid and robust antidepressant-like effects at well-tolerated doses in rodents.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Non-sedative cortical EEG signatures of allopregnanolone and functional comparators.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

A AhnaouDepartment of Neuroscience Discovery, Janssen Research &Development, A Division of Janssen Pharmaceutica NV, Beerse, Belgium.
H HuysmansDepartment of Neuroscience Discovery, Janssen Research &Development, A Division of Janssen Pharmaceutica NV, Beerse, Belgium.
R BiermansDepartment of Neuroscience Discovery, Janssen Research &Development, A Division of Janssen Pharmaceutica NV, Beerse, Belgium.
N V ManyakovDepartment of Neuroscience Discovery, Janssen Research &Development, A Division of Janssen Pharmaceutica NV, Beerse, Belgium.
W H I M DrinkenburgDepartment of Neuroscience Discovery, Janssen Research &Development, A Division of Janssen Pharmaceutica NV, Beerse, Belgium.
Janssen (Belgium) · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, the N-methyl-d-aspartate-receptor (NMDAR) antagonist ketamine has emerged as a fast-onset mechanism to achieve antidepressant activity, whereas its psychomimetic, dissociative and amnestic effects have been well documented to pharmacologically model schizophrenia features in rodents. Sleep-wake architecture, neuronal oscillations and network connectivity are key mechanisms supporting brain plasticity and cognition, which are disrupted in mood disorders such as depression and schizophrenia. In rats, we investigated the dynamic effects of acute and chronic subcutaneous administration of ketamine (2.5, 5 and 10 mg kg

Indexed as

AnimalsAntidepressive AgentsBrain WavesElectroencephalography Phase SynchronizationEvoked PotentialsKetamineMaleMotor ActivityNerve NetRatsRats, Sprague-DawleyReceptors, N-Methyl-D-AspartateSleepWakefulnessAntidepressive AgentsKetamineReceptors, N-Methyl-D-Aspartate

Identifiers

PMID28926001
PMCPMC5639243
OpenAlexW2754676563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.